Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.

Patchett, Amanda L; Tovar, Cesar; Blackburn, Nicholas B; Woods, Gregory M; Lyons, A Bruce

Patchett, Amanda L; Tovar, Cesar; Blackburn, Nicholas B; Woods, Gregory M; Lyons, A Bruce.

Afiliação

Patchett AL; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Tovar C; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Blackburn NB; School of Medicine, University of Tasmania, Hobart, TAS, Australia.
Woods GM; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Lyons AB; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Immunol Cell Biol ; 99(7): 711-723, 2021 08.

Article em En | MEDLINE | ID: mdl-33667023

Assuntos

Neoplasias Faciais; Marsupiais; Vacinas; Animais; Neoplasias Faciais/terapia; Humanos; Imunoterapia; Vacinação

Palavras-chave

Devil Facial Tumour Disease; Tasmanian devil; cancer vaccine; epithelial-to-mesenchymal transition; mesenchymal plasticity; transmissible cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Faciais / Vacinas / Marsupiais Limite: Animals / Humans Idioma: En Revista: Immunol Cell Biol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google